The European Hematology Association Roadmap for European Hematology Research: a consensus document

Haematologica
Andreas EngertEHA Roadmap for European Hematology Research

Abstract

The European Hematology Association (EHA) Roadmap for European Hematology Research highlights major achievements in diagnosis and treatment of blood disorders and identifies the greatest unmet clinical and scientific needs in those areas to enable better funded, more focused European hematology research. Initiated by the EHA, around 300 experts contributed to the consensus document, which will help European policy makers, research funders, research organizations, researchers, and patient groups make better informed decisions on hematology research. It also aims to raise public awareness of the burden of blood disorders on European society, which purely in economic terms is estimated at €23 billion per year, a level of cost that is not matched in current European hematology research funding. In recent decades, hematology research has improved our fundamental understanding of the biology of blood disorders, and has improved diagnostics and treatments, sometimes in revolutionary ways. This progress highlights the potential of focused basic research programs such as this EHA Roadmap.The EHA Roadmap identifies nine 'sections' in hematology: normal hematopoiesis, malignant lymphoid and myeloid diseases, anemias and related diseases, ...Continue Reading

Citations

Aug 2, 2016·The Lancet. Haematology·Ramon Luengo-FernandezJose Leal
Aug 2, 2016·The Lancet. Haematology·Tony GreenPieter Sonneveld
Oct 28, 2016·Expert Review of Medical Devices·Yunus AlapanUmut A Gurkan
Dec 15, 2016·Expert Review of Hematology·Sandra Capellera-Garcia, Johan Flygare
Jan 18, 2017·Expert Review of Hematology·Maria GavriatopoulouEvangelos Terpos
Apr 19, 2018·The New England Journal of Medicine·Alexis A ThompsonMarina Cavazzana
May 8, 2018·Oncology Research and Treatment·Marie von Lilienfeld-Toal, Georg Maschmeyer
Jul 14, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·P ChowdaryC Kessler
Oct 20, 2018·British Journal of Haematology·Stephan LobitzUNKNOWN with the endorsement of EuroBloodNet, the European Reference Network in Rare Haematological Diseases
Dec 21, 2018·Expert Review of Hematology·Paolo GreseleEmanuela Falcinelli
Nov 8, 2019·Blood Advances·Steven HeshusiusEmile van den Akker
Jul 24, 2020·BMJ Open·Gabriela Amstad BencaiovaIrene Hoesli
Nov 1, 2016·Personalized Medicine·Li Zhang
Apr 17, 2018·HemaSphere·Domenico GirelliClara Camaschella
Sep 25, 2020·Asia-Pacific Journal of Clinical Oncology·Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares
Jun 13, 2020·Frontiers in Physiology·Lars Kaestner, Paola Bianchi
Dec 8, 2020·The New England Journal of Medicine·Haydar FrangoulSelim Corbacioglu
Feb 6, 2021·Expert Review of Hematology·Elisa FermoPaola Bianchi
Dec 16, 2020·Blood Reviews·Alessandro Pecci, Carlo L Balduini
Sep 4, 2021·HemaSphere·Carlo BalduiniChristel Van Geet
Sep 4, 2021·HemaSphere·Hartmut DöhnerAgnieszka Wierzbowska

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Yasusada Miura
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Mine Harada
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Paolo Perseghin
The Lancet. Psychiatry
Til WykesROAMER consortium
© 2021 Meta ULC. All rights reserved